ARS Investor Fights To Keep Citigroup In Court

Law360, New York (November 11, 2009, 1:23 PM EST) -- Braintree Laboratories Inc. has appealed a federal court’s decision to order arbitration in its lawsuit accusing Citigroup Inc.’s brokerage division of pushing the specialty pharmaceutical company to buy more than $41 million of virtually worthless auction rate securities.

On Tuesday the plaintiff turned to the U.S. Court of Appeals for the First Circuit, seeking to overturn the arbitration order and win a preliminary injunction requiring Citigroup to fork over the $41.5 million Braintree spent, plus interest, or pledge property to secure that amount.

Judge Nathaniel M....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.